Mesynthes LImited, backed by MOVAC, has received a significant acknowledgement by winning the Wellington Supreme Gold award last night. Founded in 2008 by Dr Brian Ward, Mesynthes has developed a unique tissue substitute, derived from the forestomach of sheep, that supports and encourages tissue growth. The product is used to promote wound healing and in plastic surgery. ┬áMesynthes received US Food and Drug Administration approval last year and expects to ship its first commercial product in the second half of 2011. ┬áRead more here…Mesynthes supreme winner at Wellington Gold Awards.
Congratulations to Brian and the rest of team.